You searched for Parkinson's - Page 14 of 20

News and Trends 17 May 2017

Danish Biotech Targeting Ion Channels Completes Private Placement

…wide range of conditions, such as obesity, type 2 diabetes, cocaine addiction, Parkinson’s, and schizophrenia, the latter being researched in collaboration with Boehringer Ingelheim. Cover image via TJmedia /Shutterstock …

May 17, 2017 - 1 minutemin - By Clara Rodríguez Fernández

Best in Biotech 22 Jan 2025

Curing ALS? Sixteen companies developing new treatments in 2025

…as C9orf72 in ALS and frontotemporal dementia. As of now, its ALS treatment is in the discovery phase, along with two other programs focused on Parkinson’s and Alzheimer’s. As its…

January 22, 2025 - 18 minutesmins - By Jules Adam

Best in Biotech 28 Jul 2022

Five companies personalizing treatments with 3D printed drugs

…3D printing of ropinirole tablets for Parkinson’s disease. 3D inkjet printing deposits liquid materials or solid suspensions layer-by-layer but each deposited layer must first be dried, or “cured,” between the…

July 28, 2022 - 5 minutesmins - By Omnia Ibrahim

Best in Biotech 15 Mar 2023

10 immunotherapy companies making waves in 2023

…diseases like Parkinson’s. ElevateBio is looking to develop iPSC-derived therapies, for which it set up a new company in 2022, in a collaborative effort with Boston Children’s Hospital, where it…

March 15, 2023 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 8 May 2020

Phase III Failure Sinks Drug for Rare Neurological Disorder

…licensed from Merck KGaA after it failed phase III trials for Parkinson’s disease — had been billed as the first therapy to become independently commercialized by Newron. Adding to the…

May 8, 2020 - 4 minutesmins - By Anita Chakraverty

News and Trends 13 Sep 2022

WhiteLab Genomics raises $10M for AI-powered genomic therapies platform

…4,000 human diseases including Alzheimer’s disease, Parkinson’s disease, cystic fibrosis, cardiovascular disease, Duchenne muscular dystrophy, and some types of cancer, originate from errors and changes in an individual’s DNA sequence….

September 13, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 28 Jan 2020

10 Scientists Behind Modern Biotech You Probably Don’t Know

…treatments for sickle-cell anemia and Parkinson’s disease using these cells. Françoise Barré-Sinoussi (born 1947) Francois Barre-Sinoussi, 2012 – International AIDS Conference in Washington DC. Photo credit: Michael Fleshman Françoise Barré-Sinoussi…

January 28, 2020 - 8 minutesmins - By Helen Albert

News and Trends 11 Jan 2023

We DUB this target ‘druggable’

…cellular health and longevity. Recently presented at the 2022 Society for Neuroscience (SfN) conference, new data from the Beth Israel Deaconess Medical Center (BIDMC) cements Parkinson’s disease (PD) as a…

January 11, 2023 - 5 minutesmins - By External Contributor

Best in Biotech 2 Apr 2024

Chicago biotech: Seven players advancing the industry

…diseases. Their lead program is VQ-101, a small molecule designed to activate glucocerebrosidase (GCase), particularly targeting Parkinson’s disease (PD) and Dementia with Lewy Bodies (DLB), a type of progressive dementia…

April 2, 2024 - 8 minutesmins - By Jules Adam

Best in Biotech 22 Aug 2024

Seven companies transforming the biotech industry in Italy

…such as certain cancers and neurodegenerative diseases like Huntington’s and Parkinson’s. The Italian biotech’s pipeline includes several FID-based candidates targeting various therapeutic areas but its pipeline is still preclinical. Its…

August 22, 2024 - 9 minutesmins - By Jules Adam

Best in Biotech 6 Oct 2022

15 biotech companies shaking up the scene in Cambridge

…and Parkinson’s disease. The company currently has six programs in its pipeline, four in-house programs in research and preclinical phases and two undisclosed partnered programs with AbbVie and Pfizer. Last…

October 6, 2022 - 9 minutesmins - By Helen Albert

In Depth 29 May 2018

Clinical Trials in Alzheimer’s Disease Are Failing: What Can Be Done?

…mental illnesses as well as neurodegenerative disorders such as Parkinson’s and Alzheimer’s. Closely linked with the microbiome is research into metabolism. “This is not yet an area sufficiently mainstream, but…

May 29, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

Danish Biotech Targeting Ion Channels Completes Private Placement

Curing ALS? Sixteen companies developing new treatments in 2025

Five companies personalizing treatments with 3D printed drugs

10 immunotherapy companies making waves in 2023

Phase III Failure Sinks Drug for Rare Neurological Disorder

WhiteLab Genomics raises $10M for AI-powered genomic therapies platform

10 Scientists Behind Modern Biotech You Probably Don’t Know

We DUB this target ‘druggable’

Chicago biotech: Seven players advancing the industry

Seven companies transforming the biotech industry in Italy

15 biotech companies shaking up the scene in Cambridge

Clinical Trials in Alzheimer’s Disease Are Failing: What Can Be Done?

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!